Literature DB >> 16596283

Apoptotic-inducing activity of novel polycyclic aromatic compounds in human leukemic cells.

Kristin R Landis-Piwowar1, Di Chen, Qiuzhi Cindy Cui, Vesna Minic, Frederick F Becker, Bimal K Banik, Q Ping Dou.   

Abstract

Persistent but relatively limited research has been devoted to the use of compounds related to polycyclic aromatic hydrocarbons (PAH) as anticancer agents. In previous reports, we have described the cytotoxicity of a number of new and novel PAH against human cancer cell lines. However, the involved molecular mechanisms of inducing cell death were not elucidated. In the current study, we describe the apoptotic pathway as apparently playing a crucial role in induced cell death in human leukemia Jurkat T cells by several diamide and diamine PAH that contain chrysene as their core aromatic ring system. Structure-activity relationships were analyzed. Importantly, no effect was demonstrated in a normal, non-transformed line of human natural killer cells. These results provide additional evidence for the potential chemotherapeutic use of PAH.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16596283

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  3 in total

1.  Polycyclic aromatic compounds as anticancer agents: Evaluation of synthesis and in vitro cytotoxicity.

Authors:  Debasish Bandyopadhyay; Jose C Granados; John D Short; Bimal K Banik
Journal:  Oncol Lett       Date:  2011-10-04       Impact factor: 2.967

2.  4-(9-Anthr-yl)-1-(3-bromo-phen-yl)spiro-[azetidine-3,9'-xanthen]-2-one.

Authors:  Ismail Celik; Mehmet Akkurt; Aliasghar Jarrahpour; Edris Ebrahimi; Orhan Büyükgüngör
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-09-26

3.  Polycyclic aromatic compounds as anticancer agents: synthesis and biological evaluation of methoxy dibenzofluorene derivatives.

Authors:  Frederick F Becker; Bimal K Banik
Journal:  Front Chem       Date:  2014-08-01       Impact factor: 5.221

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.